
Several major companies reported their earnings before the market opened on October 16, 2024. Morgan Stanley (MS) reported an EPS of $1.88, beating the estimate of $1.59, and revenue of $15.38 billion, surpassing the forecast of $14.35 billion. The company's pre-market stock price rose by 3.40%, driven by strong Wealth Management, investment banking, and trading revenue. Abbott Labs (ABT) announced an EPS of $1.21, slightly above the estimate of $1.20, and revenue of $10.64 billion, exceeding the forecast of $10.55 billion. Despite these positive results, the company’s pre-market stock price fell by 0.3% after narrowing its FY outlook and announcing a $7 billion share buyback program. US Bancorp (USB) also reported an EPS of $1.03, beating the estimate by $0.04, but its revenue of $6.83 billion missed expectations. The company's pre-market stock price increased by 3%, despite net charge-offs being slightly above expectations.
🇺🇸US Pre-Markets ES flat, NQ +0.1%, RTY +0.7%, YM flat EARNINGS $MS +3.8%: Beat on EPS and revenue with strong Wealth Management, IB and trading revenue. $USB +3%: Topped EPS and NII forecasts; net charge-offs slightly above expectations. $ABT -0.7%: Q3 earnings beat; Q4 and…
Wednesday Morning’s Earnings Round-Up Abbott Labs $ABT EPS of $1.21 beat by $0.01 ✅ Revenue of $10.64B beat by $90M ✅ Morgan Stanley $MS EPS of $1.88 beat by $0.30 ✅ Revenue of $15.38B beat by $1.09B ✅ US Bancorp $USB EPS of $1.03 beat by $0.04 ✅ Revenue of $6.83B missed…
Pre-Market Earnings - 10.16.24 $MS | Morgan Stanley 🔹 EPS: $1.88 vs. $1.59 est. ✅ 🔹 Revenue: $15.38B vs. $14.35B est. ✅ 🔸 PM: +3.40% 📈 $ABT | Abbott Labs 🔹 EPS: $1.21 vs. $1.20 est. ✅ 🔹 Revenue: $10..64B vs. $10.55B est. ✅ 🔸 Narrows FY outlook 🟠 🔸 Announces $7B in…